PharmaLundensis AB reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported net loss was SEK 0.797215 million compared to SEK 1.27 million a year ago. Basic loss per share from continuing operations was SEK 0.02 compared to SEK 0.05 a year ago.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.36 SEK | +1.69% |
|
-.--% | -20.70% |
05-16 | PharmaLundensis AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
02-15 | PharmaLundensis AB Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
- Stock Market
- Equities
- PHAL Stock
- News PharmaLundensis AB
- PharmaLundensis AB Reports Earnings Results for the First Quarter Ended March 31, 2023